ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 379

Validation of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis

Linda Rasch1, Marian de van der Schueren2, Lilian van Tuyl1, Irene Bultink1 and Willem Lems1, 1Amsterdam Rheumatology and immunology Center, location VU University Medical Center, Department of Rheumatology, Amsterdam, Netherlands, 2Department of Nutrition and Dietetics, VU University Medical Center, Amsterdam, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Calcium, dietary supplements, osteoporosis and questionnaires, Validity

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Calcium supplements are prescribed for prevention of osteoporotic fractures, but excess intake has been associated with cardiovascular events. The most adequate tools for estimating dietary calcium intake are time-consuming, while an accurate estimation is a prerequisite to be able to prescribe the adequate amount of supplementation. The aim of this study is to validate a Short Calcium Intake List (SCaIL) that is feasible in daily clinical practice, with an extensive dietary history (DH) as reference method.

Methods: Based on the Dutch food groups which contribute most to daily dietary calcium intake and on portion sizes determined in our earlier validation study, a new three-item, one minute SCaIL was designed. As a reference method, an extensive DH with specific focus on calcium products and extra attention for portion sizes was performed. Beforehand, a difference of ≥250 mg calcium between both methods was considered clinically relevant.

Results: Sixty-six patients with either primary (n=40) or secondary (n=26) osteoporosis were included. The SCaIL showed a very small and clinically non-relevant difference with the DH: mean 24 ± 350 mg calcium per day (1146 ± 440 vs 1170 ± 485, respectively; p=0.568). Sensitivity and specificity of the SCaIL, compared to the DH, were 73% and 80%, respectively. However, in 50% of the individuals, a clinically relevant difference was observed between both methods, while in 17% a difference of ≥500 mg was observed.

Conclusion: The SCaIL is a quick and easy questionnaire to estimate dietary calcium intake at a group level, but is not sufficiently reliable for use in individual patients. Remarkably, mean dietary calcium intake via the DH is 1170 mg per day, which indicates that a large proportion of osteoporosis patients might not even need calcium supplementation.


Disclosure: L. Rasch, None; M. de van der Schueren, None; L. van Tuyl, None; I. Bultink, None; W. Lems, None.

To cite this abstract in AMA style:

Rasch L, de van der Schueren M, van Tuyl L, Bultink I, Lems W. Validation of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/validation-of-a-short-calcium-intake-list-to-estimate-daily-dietary-calcium-intake-of-patients-with-osteoporosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-a-short-calcium-intake-list-to-estimate-daily-dietary-calcium-intake-of-patients-with-osteoporosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology